Let me tell you something that’s been gnawing at me for weeks: the Australian stock market is currently playing a game of chess with invisible pieces. The ChartWatch ASX scans, with their neatly packaged uptrends and downtrends, feel less like a roadmap and more like a Rorschach test. What makes this particularly fascinating is how these lists force us to confront the uncomfortable truth that technical analysis is as much about psychology as it is about numbers. Take Oncosil Medical (OSL), which has surged 171% in a month. That’s not just a stock moving—it’s a mirror held up to the collective panic and hope of investors. But why? What’s the deeper narrative here?
Let’s start with the uptrends. The list reads like a who’s who of market oddities. Havilah Resources (HAV) is up 327% year-over-year, while Hammer Metals (HMX) clocks in at 91.7%. These aren’t just numbers—they’re stories of desperation and speculation. I can’t help but think of the mining sector as a casino for retail investors, where every 10% move feels like a jackpot. But what’s the real driver? Is it genuine demand for lithium or cobalt, or is this just a liquidity-driven frenzy? The answer probably lies in the intersection of geopolitical tensions and the electric vehicle boom, but I’m not sure we’ve fully unpacked that yet.
Then there’s Macquarie (MQG), a financial heavyweight with a modest 3.7% one-month gain. This feels like the elephant in the room. Why isn’t this bank exploding higher? It’s not just about interest rates—it’s about trust. Macquarie’s performance whispers of a broader crisis of confidence in institutional players. In my opinion, the financial sector is currently in a state of quiet rebellion against traditional valuation models. The fact that even a 3.7% move is considered a ‘trend’ says more about the market’s current fragility than it does about the company’s fundamentals.
Now let’s pivot to the downtrends. Myer (MYR) is flat year-over-year, but that’s not the story I’m interested in. What’s haunting me is the presence of Xero (XRO), which is down 60.4% annually. Xero’s decline isn’t just about competition—it’s about the existential threat of AI to entire business models. If you take a step back and think about it, SaaS companies are now the new dot-coms, and Xero’s performance is a warning shot across the bow. This raises a deeper question: are we witnessing the first wave of AI-driven obsolescence in the tech sector, or is this just a temporary correction?
The most intriguing part of this whole exercise is the methodology itself. Carl Capolingua’s trend-following approach is elegant in its simplicity, but I find myself wondering if it’s a double-edged sword. When you reduce stocks to mere lines on a chart, you risk missing the human element—the boardroom politics, the regulatory shifts, the cultural tides. A detail that I find especially interesting is how often these lists repeat the same names. It’s like watching a broken record, and it makes me wonder: are we chasing ghosts, or are we just too lazy to dig deeper?
What many people don’t realize is that these scans are more reflective of market sentiment than they are predictive. The fact that Pexa (PXA) is down 40.5% annually while Telstra (TLS) is only down 4.5% tells a story about the diverging trajectories of legacy businesses versus disruptors. Telstra’s muted decline feels like a defensive play—investors are clinging to the safety of a telecom giant even as the world shifts toward 5G and fiber. Meanwhile, Pexa’s freefall screams of the risks inherent in the legal tech space, where innovation is outpacing regulation at a dangerous rate.
This whole exercise makes me think about the future of investing. Are we heading toward a world where technical analysis becomes obsolete, replaced by algorithms that can parse sentiment from social media posts or predict mergers based on CEO tweets? Or is this just another phase in the endless cycle of market fads? One thing is certain: the ASX is currently a microcosm of a larger global shift toward volatility-driven investing, where the line between opportunity and madness is getting thinner by the day. If you’re not questioning every number on these lists, you’re not paying attention—and in today’s market, that could be the cost of your portfolio.
